HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gottlieb Highlights Drawback To Increasing FDA Salaries: Resource Disparity

This article was originally published in The Rose Sheet

Executive Summary

FDA commissioner tells agency stakeholders that there could be intra-agency moves to centers and offices that can offer higher pay.

You may also be interested in...



FDA's Hiring Advantage: Scores In Best Places To Work Survey Continue To Rise

US agency ranks 32nd out of 150 agency subcomponents in annual survey of employees.

US FDA Taps Pfizer Executive For CDER Deputy Director Slot

Patrizia Cavazzoni, Janet Woodcock's new #2, has a background similar to Richard Moscicki, CDER's previous deputy director for operations.

US FDA Hiring Initiative Aims To Get Scientific Staff More Involved In Recruitment

Commissioner Gottlieb's pilot program also creates dedicated recruitment staff that will work to fill prescription drug user fee-related openings, streamline the hiring process and improve employee retention.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel